vancomycin-resistant enterococci

The financing will go toward efforts by the German firm to bring its point-of-care screening system for drug-resistant bacteria to hospitals. 

Researchers described a vancomycin-resistant Enterococcus infection transmitted from a liver donor to recipient, ruling out hospital-acquired infection with genomics.

A retrospective analysis of Enterococcus faecium isolates from a UK hospital provided clues to infection sources and antibiotic resistance patterns.

NEW YORK (GenomeWeb News) — IMDx said today that its IMDx VanR assay for the Abbott m2000 platform has received regulatory clearance from Health Canada and Singapore's Health Sciences Authority, allowing the test to be sold and distributed in those countries.

As one of its major molecular diagnostics-related revenue sources begins to slow down, Qiagen today outlined its plan to replace it with several new MDx initiatives and other molecular biology-related growth drivers.

NEW YORK (GenomeWeb News) – IntelligentMDx today announced it has received clearance from the US Food and Drug Administration for its molecular diagnostic test for vancomycin-resistant enterococci.

Seegene this week introduced the Anyplex II STI-7 detection assay, a multiplex real-time PCR assay for several sexually transmitted infectious agents.

The collaboration will combine microfluidic PCR technology licensed from Caliper Life Sciences and various innovations from Canon's imaging and printing products with sample prep, digital PCR, and sequencing components from UMD researchers.

The new funds follow a $3.3 million Series C financing round closed in late 2009. MDI will use the money to further develop its pipeline of qualitative real-time PCR in vitro diagnostic tests for infectious diseases.

Cepheid also recently inked sole-source agreements with two separate entities to conduct surveillance of methicillin-resistant Staphylococcus aureus using its GeneXpert platform, company officials said last week.

Pages

CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.